DIN 02340666 — PRIMOVIST 181.43 MG
PRIMOVIST is a solution of Gadoxetate marketed by BAYER INC. The full Gadoxetate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02340666
- Brand name
- PRIMOVIST
- Active ingredient
- Gadoxetate
- Strength
- 181.43 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- BAYER INC
- Health Canada status
- MARKETED
- Drug class
- Gadolinium-based, liver-specific (hepatobiliary) MRI contrast agent
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.